Ontology highlight
ABSTRACT: Purpose
To describe baseline vision-related function, measured with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25), in patients with macular edema secondary to central retinal vein occlusion (CRVO) or hemiretinal vein occlusion (HRVO) in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2); evaluate the baseline relationship between NEI VFQ-25 scores with visual acuity letter score (VALS) and central retinal thickness; and compare baseline NEI VFQ-25 scores in SCORE2 participants with those in normal-vision reference populations and patients in other retinal vein occlusion trials.Design
Multicenter, noninferiority randomized controlled trial.Methods
SCORE2 was designed to assess whether intravitreal bevacizumab is noninfer
SUBMITTER: Scott IU
PROVIDER: S-EPMC5798626 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature